It is known that 53% of patients with CMD have homozygous or compound heterozygous variants in one of six known CMD genes, 10% have homozygous or compound heterozygous variants in POMGNT1, and the incidence of CMD is estimated to be 1:21,500 [48, 49]. This evidence concerns the gene POMGNT1 and congenital muscular dystrophy.